How CVS and Wal­greens are be­com­ing phar­ma’s new big ad­ver­tis­ing strat­e­gy

Phar­ma mar­keters are spend­ing more mon­ey and time tar­get­ing re­tail phar­ma­cies — and their video dis­plays, mo­bile phone alerts and even re­frig­er­a­tor doors — as the num­ber of con­sumers re­ceiv­ing pri­ma­ry care ser­vices in re­tail stores ris­es.

More than half (58%) of Amer­i­cans are like­ly to go to phar­ma­cies as a first step for non-emer­gency health­care, ac­cord­ing to a Wolters Kluw­er sur­vey in May. When it comes to vac­cines, 62% of adults said they would go to a phar­ma­cy, al­though 54% still pre­fer physi­cian of­fice vis­its for their chil­dren’s shots.

Big re­tail phar­ma­cies are ready to serve them.

Ma­jor re­tail chains have long op­er­at­ed clin­ics in­side their stores, go­ing back to the first Min­ute­Clin­ic open­ing in­side a CVS in 2000. (The re­tail phar­ma­cy chain lat­er ac­quired the provider in 2006.) Over the last decade, as Big Tech moved fur­ther in­to clin­i­cal care, re­tail­ers like CVS and Wal­greens upped their own in­vest­ment in the area. How­ev­er, it was the Covid-19 pan­dem­ic that ac­cel­er­at­ed the growth of clin­i­cal ser­vices in re­tail stores, dri­ven in part by vac­ci­na­tions.

More than 90% of Covid vac­cines were de­liv­ered at phar­ma­cies, ac­cord­ing to an IQVIA re­port an­a­lyz­ing da­ta through last year. How­ev­er, shin­gles vac­cines al­so saw “a ma­jor­i­ty of ad­min­is­tra­tion” from 2018 to 2022, along with up to a 40% in­crease in flu vac­ci­na­tions at phar­ma­cies be­tween the 2018/2019 and 2020/2021 flu sea­sons.

Phar­ma mar­keters are fol­low­ing along, in­creas­ing­ly craft­ing strate­gies that tar­get con­sumers and phar­ma­cists alike, ex­perts said.

Eliz­a­beth Dex­ter

“Pri­ma­ry care is no longer hap­pen­ing ex­clu­sive­ly in a tra­di­tion­al doc­tor’s of­fice,” said Eliz­a­beth Dex­ter, VP of point of care at Pub­li­cis Health Me­dia. “We’re see­ing this as an enor­mous evo­lu­tion to fit the chang­ing be­hav­iors of Amer­i­cans. We’re re­al­ly ex­cit­ed about this and see a great op­por­tu­ni­ty for many of our brands in the space.”

PHM added a ded­i­cat­ed point of care team at PHM sev­er­al years ago not on­ly for tra­di­tion­al physi­cian’s of­fices and hos­pi­tals point of care, but al­so emerg­ing lo­ca­tions such as re­tail phar­ma­cies and tele­health.

GSK has done in-store phar­ma­cy ad­ver­tis­ing in the past, but its newest mar­ket­ing strat­e­gy for res­pi­ra­to­ry syn­cy­tial virus vac­cine Arexvy in­cludes a con­cert­ed re­tail phar­ma­cy ef­fort and out­reach to phar­ma­cists.

“Our hope is that con­sumers will see our in­for­ma­tion at their lo­cal phar­ma­cy and have that con­ver­sa­tion. We al­so plan to sup­port phar­ma­cists with re­sources and pa­tient ed­u­ca­tion to help fa­cil­i­tate dis­cus­sions and ul­ti­mate­ly vac­ci­na­tions,” a GSK spokesper­son said in an email.

Sanofi has “seen, year-over-year, a greater shift from med­ical to re­tail” and al­so is con­sid­er­ing that change in its mar­ket­ing plans, said Do­mini­ka Ko­vacs, Sanofi’s head of adult vac­cines in the US.

Do­mini­ka Ko­vacs

For its cur­rent flu vac­cine cam­paign, which fea­tures a wolf in sheep’s cloth­ing to il­lus­trate the lurk­ing dan­ger of flu, that im­agery will be used in­side re­tail phar­ma­cies to “nudge” peo­ple to con­sid­er Sanofi flu vac­cines, she said. Its brand­ed TV ads for Flu­zone and Flublok, which are cur­rent­ly run­ning, en­cour­age peo­ple to “Ask your phar­ma­cist or doc­tor” about its vac­cines. The fi­nal screen of the com­mer­cial lists the names of its phar­ma­cy part­ners, in­clud­ing CVS, Kroger, Rite Aid, Wal­greens and Wal­mart.

But it’s not just vac­cine mak­ers that should be think­ing about re­tail phar­ma­cy as a mar­ket­ing venue.

Dex­ter is bull­ish on the op­por­tu­ni­ty for most pre­scrip­tion drugs, say­ing, “I can hon­est­ly make a case for near­ly any Rx prod­uct on the val­ue of be­ing in phar­ma­cy — even if it’s a spe­cial­ty prod­uct.”

She gave an ex­am­ple of an un­named bi­o­log­ic pso­ri­a­sis med­i­cine that is on­ly avail­able at spe­cial­ty phar­ma­cies, not­ing that peo­ple with pso­ri­a­sis who are not on ther­a­py are like­ly al­ready spend­ing time in re­tail phar­ma­cies look­ing for OTC skin­care prod­ucts or pick­ing up pre­scrip­tion gener­ic drugs. If they see an ad for a bi­o­log­ic while pick­ing up those items, it could mo­ti­vate them to talk to their doc­tor about oth­er treat­ment op­tions.

The op­por­tu­ni­ties aren’t lim­it­ed on­ly to phys­i­cal stores. VM­LY&R Health, which worked with Pfiz­er on its Covid-19 vac­cine cam­paigns, sees so­cial me­dia as an­oth­er way to in­flu­ence phar­ma­cists as well, said Bri­an Owens, SVP of com­merce strat­e­gy for VM­LY&R Com­merce.

“Be­cause of the el­e­vat­ed role of the phar­ma­cist in health­care, now that they’re more of a pri­ma­ry care provider, re­tail phar­ma­cy has cre­at­ed op­por­tu­ni­ties,” he said. “And be­cause of the so­cial me­dia phe­nom­e­non and in­flu­encer mar­ket­ing, re­tail­ers are adapt­ing and trans­form­ing or mon­e­tiz­ing spaces, is prob­a­bly the best way to de­scribe it…[There are] more dig­i­tal screens around the phar­ma­cy, more QR codes in store. And if you go to a CVS or Tar­get, you might even see pic­tures of in­flu­encers [on the] shelf.”

Mean­while, sta­ple in-store phar­ma ad for­mats like shelf talk­ers and end cap dis­plays are evolv­ing, too. Video screen dis­plays, click­able QR codes and dig­i­tal ad­ver­tis­ing that al­low con­sumers to opt-in from their mo­bile phones are some of the new­er ways phar­ma com­pa­nies are try­ing to reach con­sumers in re­tail set­tings.

Lin­dell Ben­nett

Cool­er Screens, which trans­forms the glass on bev­er­age and snack cool­ers in stores in­to ad­ver­tis­ing screens, is now do­ing work with phar­ma com­pa­nies, said chief rev­enue of­fi­cer Lin­dell Ben­nett.

He joined the com­pa­ny about 18 months ago af­ter 10 years at Ama­zon, most re­cent­ly run­ning its con­sumer pack­aged goods busi­ness.

“Whether it’s with­in phar­ma­ceu­ti­cals or Proc­ter & Gam­ble or any brand, you name it, a lot of them are talk­ing about how be­ing at the point of re­tail in a phys­i­cal store is be­com­ing more and more cen­tral to what they do,” he said.

For phar­ma mar­keters, though, it’s im­por­tant to be thought­ful about the types of mes­sages peo­ple will ac­cept at re­tail.

“If you’re go­ing to a phar­ma­cy or pri­ma­ry point of care in the store, you don’t want to feel like you’re be­ing sold to,” he said. “But from an ed­u­ca­tion­al stand­point, you do want peo­ple to un­der­stand what op­tions they have.”